Literature DB >> 12434310

Aqueous humor levels of topically applied levofloxacin in human eyes.

Masakazu Yamada1, Hiroshi Mochizuki, Kyoko Yamada, Masataka Kawai, Yukihiko Mashima.   

Abstract

PURPOSE: To evaluate transcorneal penetration of topically applied 0.5% levofloxacin into the aqueous humor in human eyes.
METHODS: Twenty cataract patients (14 females, 6 males) received 3 drops of 0.5% levofloxacin at 15 min intervals from 90 minutes before the surgery. At the beginning of the cataract surgery, 50 microL of aqueous humor was aspirated from the anterior chamber and stored at -80 degrees C until analysis. The drug concentration of the samples was analyzed using high-performance liquid chromatography.
RESULTS: A mean aqueous humor level of levofloxacin was 1.00 +/- 0.48 microg/mL (mean +/- standard deviation, n = 20), ranging from 0.30 microg/mL to 2.32 microg/mL.
CONCLUSIONS: The mean concentration of levofloxacin in the aqueous humor was higher than the MIC(90) values against some common pathogens of postoperative endophthalmitis, although a great degree of interpatient variability was present.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12434310     DOI: 10.1076/ceyr.24.5.403.8517

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  6 in total

1.  Pathogens and antibiotic sensitivities in endophthalmitis.

Authors:  Geraldine R Slean; Neal H Shorstein; Liyan Liu; John F Paschal; Kevin L Winthrop; Lisa J Herrinton
Journal:  Clin Exp Ophthalmol       Date:  2017-01-31       Impact factor: 4.207

2.  Levofloxacin disposition over time in aqueous humor of patients undergoing cataract surgery.

Authors:  Federico Pea; Ettore Ferrari; Federica Pavan; Derri Roman-Pognuz; Francesco Bandello; Mario Furlanut
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

3.  [The effectiveness of the new fluoroquinolones against the normal bacterial flora of the conjunctiva].

Authors:  M J Koss; M Eder; M S Blumenkranz; V Klauss; C N Ta; H M de Kaspar
Journal:  Ophthalmologe       Date:  2007-01       Impact factor: 1.059

4.  Human intraocular penetration pharmacokinetics of moxifloxacin 0.5% via topical and collagen shield routes of administration.

Authors:  Seenu M Hariprasad; William E Mieler; Gaurav K Shah; Kevin J Blinder; Rajendra S Apte; Nancy M Holekamp; Matthew A Thomas; Jingduan Chi; Randall A Prince
Journal:  Trans Am Ophthalmol Soc       Date:  2004

5.  Development of topical chitosan/ β-glycerophosphate-based hydrogel loaded with levofloxacin in the treatment of keratitis: An ex-vivo study.

Authors:  Yu-Fan Chang; Yung-Hsin Cheng; Yu-Chieh Ko; Shih-Hwa Chiou; Catherine Jui-Ling Liu
Journal:  Heliyon       Date:  2021-12-30

6.  Aqueous humour concentrations after topical apPlication of combinEd levofloxacin-dexamethasone eye dRops and of its single components: a randoMised, assEssor-blinded, parallel-group study in patients undergoing cataract surgery: the iPERME study.

Authors:  Michele Figus; Chiara Posarelli; Dario Romano; Marco Nardi; Luca Rossetti
Journal:  Eur J Clin Pharmacol       Date:  2020-04-13       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.